A more global anti-cancer approach involves conditionally replicating adenoviruses (Ads), both Ad.5 and Ad.5/3 chimeric viruses, and engineering them to use the pPEG (or pGAPE) to control Ad E1A and E1B expression. Here, DHTKD1 is linked to cancer.